Policy Notices

• NIH Redesign of the xTrain Module in eRA Commons
  (NOT-OD-23-094)
  National Institutes of Health
  

• Expiration of the COVID-19 Public Health Emergency
  (NOT-OD-23-095)
  National Institutes of Health
  

• NIH Can No Longer Grant Common Rule Exceptions to the Use of a Single IRB for Multi-site Research After the COVID-19 Public Health Emergency Expiration Date of May 11, 2023
  (NOT-OD-23-097)
  Office of the Director, NIH
  

General Notices

• Notice of Pre-Application Webinar for RFA-AG-24-011 - Research Coordinating Center on the Exposome and AD/ADRD: Elucidating the Role of Social and Behavioral Determinants of Health in AD/ADRD Etiology and Disparities (U24 Clinical Trial Not Allowed)
  (NOT-AG-23-010)
  National Institute on Aging
  

• Notice of Pre-Application Webinar for Funding Opportunities on Determinants of Differences Among Human and Nonhuman Primate Species in Life Spans, Life Histories, and Other Aging-Related Outcomes, and Prospects for Translation
  (NOT-AG-23-011)
  National Institute on Aging
  

• Notice of Clarification to the NIBIB R21 Trailblazer Program (PAR-24-022)
  (NOT-EB-23-003)
  National Institute of Biomedical Imaging and Bioengineering
  

• Notice to Extend the Expiration Date for All NIH Career Development Award (K) Parent Announcements
  (NOT-OD-23-096)
  Office of the Director, NIH
  

• The National Institutes of Health (NIH) Sexual & Gender Minority Research Office Request for Nominations for 2023 SGM Research Investigator Awards Program
  (NOT-OD-23-100)
  Office of the Director, NIH
  

• Notice of Pre-Application Webinar for PAR-23-035: Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
  (NOT-RM-23-007)
  Office of Strategic Coordination (Common Fund)
  

• Request for Information (RFI): Advancing Clinical and Translational Science through Accelerating the Decentralization of Clinical Trials
  (NOT-TR-23-006)
  National Center for Advancing Translational Sciences
  

Notice of Changes to Funding Opportunities

• Notice of Change to the Application Due Date and Correction of Budget Submission Requirement for RFA-CA-23-002 "Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)"
  (NOT-CA-23-047)
  National Cancer Institute
  

• Notice of Changes to Application Submission Instructions for RFA-DA-22-040, "High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)"
  (NOT-DA-23-020)
  National Institute on Drug Abuse
  

• Notice to Extend the Expiration Date of PAR-20-213 "National Institute of General Medical Sciences Institutional Predoctoral Research Training Grant (T32 - Clinical Trial Not Allowed)"
  (NOT-GM-23-036)
  National Institute of General Medical Sciences
  

• Notice to Extend the Expiration Date for PA-20-163 Competing Revisions to Existing NIH Grants and Cooperative Agreements (Clinical Trial Optional)
  (NOT-OD-23-101)
  National Institutes of Health
  National Human Genome Research Institute
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Bioinformatics Resource Centers (BRCs) for Infectious Diseases (U24 Clinical Trials Not Allowed)
  (NOT-AI-23-033)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Intent to Reissue PA-20-208, Substance Use/Substance Use Disorder Dissertation Research Award
  (NOT-DA-23-018)
  National Institute on Drug Abuse
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Established Data Repositories and Knowledgebases (Clinical Trials Not Allowed)
  (NOT-OD-23-099)
  Office of the Director, NIH
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions to Add or Expand Research and Administrative Supplements on Cutting Edge Pain Research in Rheumatic, Skin, and Musculoskeletal Disease.
  (NOT-AR-23-015)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Special Interest (NOSI): Administrative Supplements to NIAMS-funded T32 Training Grants to Better Incorporate Pain Related Research in Rheumatic, Skin and Musculoskeletal Diseases Workforce Development
  (NOT-AR-23-016)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Special Interest (NOSI): Administrative supplements to examine the effects of digital tools and interventions on patient-provider communication across the cancer control continuum
  (NOT-CA-23-041)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Administrative Supplements for NCI Division of Cancer Biology Research Programs
  (NOT-CA-23-045)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Administrative Supplements to Leverage Network Infrastructure to Advance Multisite Research for Women, Children, Pregnant and Lactating Individuals and/or Persons with Disabilities
  (NOT-HD-23-005)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Special Interest (NOSI): Administrative Supplements to NINR Institutional Research Training Grants (T32) to Increase Capacity for Research to Prevent Firearm Injury and Related Health Disparities
  (NOT-NR-23-009)
  National Institute of Nursing Research
  

Funding Opportunities

• Limited Competition: NIDDK Program Projects (P01 Clinical Trial Optional)
  (PAR-23-121)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): February 07, 2024
  
  

• Genomic Community Resources (U24 Clinical Trial Not Allowed)
  (PAR-23-124)
  National Human Genome Research Institute
  National Cancer Institute
  Application Receipt Date(s): January 25, 2026
  
  

• Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
  (PAR-23-130)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  National Institute of Mental Health
  Office of Research on Women's Health
  Application Receipt Date(s): May 07, 2026
  
  

• Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
  (PAR-23-131)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  Office of Research on Women's Health
  Application Receipt Date(s): May 07, 2026
  
  

• NIMH Mentoring Networks for Mental Health Research Education (R25 Clinical Trial Not Allowed)
  (PAR-23-263)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• NIMH Short Courses for Mental Health Related Research (R25 -Independent Clinical Trial Not Allowed)
  (PAR-23-265)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• NIMH Research Education Programs for Psychiatry Residents (R25- Independent Clinical Trial Not Allowed)
  (PAR-23-266)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Roybal Centers for Translational Research on Aging (P30 Clinical Trial Required)
  (RFA-AG-24-006)
  National Institute on Aging
  Application Receipt Date(s): June 23, 2023
  
  

• Roybal Centers for Translational Behavioral Research on Dementia Care, Caregiver Support, and Prevention of Alzheimers Disease and Related Dementias (AD/ADRD) (P30 Clinical Trial Required)
  (RFA-AG-24-007)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Edward R. Roybal Coordinating Center (R24 - Clinical Trial Not Allowed)
  (RFA-AG-24-008)
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed)
  (RFA-AG-24-014)
  National Institute on Aging
  Application Receipt Date(s): October 18, 2024
  
  

• Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required)
  (RFA-AG-24-015)
  National Institute on Aging
  Application Receipt Date(s): October 18, 2024
  
  

• Research Network to Promote Multidisciplinary Mechanistic and Translational Studies of Sickle Cell Disease Pain (U24, Clinical Trial Optional)
  (RFA-AT-24-001)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): October 01, 2023
  
  

• Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (R01 Clinical Trial Not Allowed)
  (RFA-DA-24-001)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 13, 2025
  
  

• Postbaccalaureate Research Education Program in Diabetes, Endocrinology and Metabolic Diseases (R25 Independent Clinical Trial not Allowed)
  (RFA-DK-22-037)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 25, 2023
  
  

• Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional)
  (RFA-ES-23-007)
  National Institute of Environmental Health Sciences
  John E. Fogarty International Center
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Disease Prevention
  Application Receipt Date(s): November 07, 2023
  
  

• Using Secondary Data Analysis to Determine Whether Preventive Interventions Implemented Earlier in Life Reduce Suicide Risk (U01 Clinical Trial Not Allowed)
  (RFA-MH-23-275)
  National Institute of Mental Health
  Application Receipt Date(s): October 10, 2023
  
  

• Advancing Integrated Models (AIM) of Care to Improve Pregnancy Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Optional)
  (RFA-NR-23-002)
  National Institute of Nursing Research
  National Institute on Minority Health and Health Disparities
  Office of Research on Women's Health
  Application Receipt Date(s): May 01, 2023
  
  

• Evaluating the Impact of Pandemic Era related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional)
  (RFA-NR-23-003)
  National Institute of Nursing Research
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  Office of Disease Prevention
  Application Receipt Date(s): May 01, 2023
  
  

• Clinical-Community Linkages to Address Social Needs and Social Conditions to Advance Health Equity among Populations Experiencing Health Disparities: The Bridge-to-Care Initiative (R01 Clinical Trial Required)
  (RFA-NR-23-004)
  National Institute of Nursing Research
  Application Receipt Date(s): May 01, 2023